← Leaderboards
William B Klimstra
University Of North Carolina Chapel Hill
$13,808,129
Attributed
$17,120,807
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2008–25$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,120,807 · 10
By mechanism
R01$15,883,849 · 7
R21$1,236,958 · 3
Top collaborators
- James E Crowe4 shared
- Michael S. Diamond4 shared
- Robyn S Klein4 shared
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Robert E. Johnston$11,943,669
- Ralph S Baric$89,182,261
- Mark T Heise$26,876,746
- Aravinda M De Silva$31,411,437
- Laura J White$5,803,604
Others in their field
Top investigators on “In Vitro”
- David Heimbrook · Leidos Biomedical Research, Inc.$553,787,942
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Dennis R. Burton · Scripps Research Institute$79,204,175
Research focus
In VitroVirusIn VivoInfectionVaccinesAlphavirusVirus ReplicationCytokineCellsCulicidaeMediatingEncephalitisAntiviral AgentsMutationVaccine DesignVirus DiseasesImmuneTropismVirulenceAnimalsReceptorDesignInterferonsPathogen
Grant awards (40)
Human Monoclonal Antibodies for Encephalitic Alphaviruses$781,163
R01 · FY2025 · AI
Viral and host factors in neuroinvasion of encephalitis alphaviruses$521,574
R01 · FY2025 · AI
Human Monoclonal Antibodies for Encephalitic Alphaviruses$798,435
R01 · FY2024 · AI
Viral and host factors in neuroinvasion of encephalitis alphaviruses$521,574
R01 · FY2024 · AI
An Informed Approach to Live Attenuated Vaccines against Encephalitis Alphaviruses$485,811
R01 · FY2024 · AI · contact PI
Human Monoclonal Antibodies for Encephalitic Alphaviruses$810,278
R01 · FY2023 · AI
Viral and host factors in neuroinvasion of encephalitis alphaviruses$616,573
R01 · FY2023 · AI
An Informed Approach to Live Attenuated Vaccines against Encephalitis Alphaviruses$486,606
R01 · FY2023 · AI · contact PI
Human Monoclonal Antibodies for Encephalitic Alphaviruses$858,139
R01 · FY2022 · AI
Viral and host factors in neuroinvasion of encephalitis alphaviruses$634,948
R01 · FY2022 · AI
Molecular mechanisms of eastern equine encephalitis virus pathogenesis$485,527
R01 · FY2022 · AI · contact PI
An Informed Approach to Live Attenuated Vaccines against Encephalitis Alphaviruses$484,389
R01 · FY2022 · AI · contact PI
An Informed Approach to Live Attenuated Vaccines against Encephalitis Alphaviruses$455,241
R01 · FY2022 · AI · contact PI
An Informed Approach to Live Attenuated Vaccines against Encephalitis Alphaviruses$477,720
R01 · FY2021 · AI · contact PI
Molecular mechanisms of eastern equine encephalitis virus pathogenesis$449,269
R01 · FY2021 · AI · contact PI
An Informed Approach to Live Attenuated Vaccines against Encephalitis Alphaviruses$472,242
R01 · FY2020 · AI · contact PI
Molecular mechanisms of eastern equine encephalitis virus pathogenesis$460,149
R01 · FY2020 · AI · contact PI
Molecular mechanisms of eastern equine encephalitis virus pathogenesis$505,741
R01 · FY2019 · AI · contact PI
Molecular mechanisms of eastern equine encephalitis virus pathogenesis$485,193
R01 · FY2018 · AI · contact PI
Molecular Mechanisms of Eastern Equine Encephalitis Virus Pathogenesis$429,258
R01 · FY2016 · AI · contact PI
Development of a novel live attenuated vaccine for eastern equine encephalitis virus$230,369
R21 · FY2016 · AI · contact PI
Characterization of microRNA binding sites in the eastern equine encephalitis virus 3'NTR$224,682
R21 · FY2016 · AI · contact PI
Molecular Mechanisms of Eastern Equine Encephalitis Virus Pathogenesis$429,258
R01 · FY2015 · AI · contact PI
A Small Animal Model for Viscerotropic Disease to Improve Yellow Fever Vaccine$345,396
R01 · FY2015 · AI · contact PI
Development of a novel live attenuated vaccine for eastern equine encephalitis virus$191,878
R21 · FY2015 · AI · contact PI
Characterization of microRNA binding sites in the eastern equine encephalitis virus 3'NTR$187,154
R21 · FY2015 · AI · contact PI
Molecular Mechanisms of Eastern Equine Encephalitis Virus Pathogenesis$441,258
R01 · FY2014 · AI · contact PI
Molecular Mechanisms of Eastern Equine Encephalitis Virus Pathogenesis$403,502
R01 · FY2013 · AI · contact PI
Efficacy of the antiviral state versus Sindbis and Venezuelan equine encephalitis$317,218
R01 · FY2013 · AI · contact PI
Molecular Mechanisms of Eastern Equine Encephalitis Virus Pathogenesis$442,133
R01 · FY2012 · AI · contact PI
Efficacy of the antiviral state versus Sindbis and Venezuelan equine encephalitis$337,466
R01 · FY2012 · AI · contact PI
Efficacy of the antiviral state versus Sindbis and Venezuelan equine encephalitis$337,466
R01 · FY2011 · AI · contact PI
Efficacy of the antiviral state versus Sindbis and Venezuelan equine encephalitis$340,875
R01 · FY2010 · AI · contact PI
Characterization of alphavirus infection receptors$183,125
R21 · FY2009 · AI · contact PI
Characterization of alphavirus infection receptors$219,750
R21 · FY2008 · AI · contact PI
MOLECULAR BASIS OF ALPHAVIRUS NEUROVIRULENCE$331,567
R01 · FY2004 · AI
MOLECULAR BASIS OF ALPHAVIRUS NEUROVIRULENCE$321,912
R01 · FY2003 · AI
MOLECULAR BASIS OF ALPHAVIRUS NEUROVIRULENCE$312,535
R01 · FY2002 · AI
MOLECULAR BASIS OF ALPHAVIRUS NEUROVIRULENCE$192,744
R01 · FY2001 · AI
MOLECULAR BASIS OF ALPHAVIRUS NEUROVIRULENCE$110,689
R01 · FY2001 · AI